Discuss MannKind Corp.
MannKind Corp.
WKN: A2DMZL / Symbol: MNKD / Name: MannKind / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
3,02 €
-0,03 %
MannKind (MNKD) had its price target lowered by Wedbush from $10.00 to $8.00. They now have an "outperform" rating on the stock.
Ratings data for MNKD provided by MarketBeat
MannKind (MNKD) was given a new $8.00 price target by Mizuho. They now have an "outperform" rating on the stock.
Ratings data for MNKD provided by MarketBeat
MannKind (MNKD) had its price target raised by Wells Fargo & Company from $7.00 to $8.00. They now have an "overweight" rating on the stock.
Ratings data for MNKD provided by MarketBeat
MannKind (MNKD) had its price target lowered by Mizuho from $8.00 to $7.00. They now have an "outperform" rating on the stock.
Ratings data for MNKD provided by MarketBeat
MannKind (MNKD) had its price target raised by HC Wainwright from $8.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for MNKD provided by MarketBeat
MannKind (MNKD) had its "overweight" rating reaffirmed by Wells Fargo & Company.
Ratings data for MNKD provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Solar Capital Ltd diskutieren